1 Summary of FDA Guidance for Industry Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages.

Slides:



Advertisements
Similar presentations
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
Advertisements

WHO Good Distribution Practices for Pharmaceutical Products
Presentation of the proposed Annex 19 – Safety Management
HIBC UDI IMPLEMENTATION FOR THE DENTAL INDUSTRY Presented to: Dental Trade Alliance March 5, 2014 Robert A. Hankin, Ph.D. HIBCC President.
TRACK N TRACE PHARMA PACKING LINE TRACK N TRACE PHARMA PACKING LINE
Radiopharmaceutical Production
EC Explosives for civil uses 22 February 2013, SSDCEI, Brussels, Explosives for civil uses Common Action Plan.
Agency Drafts Statement of Scope Governor Approves (2) No Agency Drafts: Special Report for rules impacting housing Fiscal Estimate.
preventing counterfeit …
ILISA B.G. BERNSTEIN, PHARM.D., J.D. U.S. Food and Drug Administration
1 Promoting Safe Medicine With Track and Trace Systems SRC Technologies, Inc.
Barcoding in the supply chain
QAD Customer Day – Santa Clara, CA QAD SERIALIZATION, ITEM ATTRIBUTES, QUALITY CONTROL & LOT TRACE WORKBENCH Simplifying Industry Compliance, Materials.
PhRMA Presentation to FDA: Bar Codes to Reduce Medication Errors
A Review ISO 9001:2015 Draft What’s Important to Know Now
Proposed Rule to Protect Food Against Intentional Adulteration 1.
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
1 Unique Device Identification (UDI) – Enabling the Transformation of Medical Device Safety Terrie Reed, MSIE Associate Director, Informatics
Overview of the New Content and Format Requirements for Prescription Drug Labeling.
The New EMC Directive 2004/108/EC and the DTI transposition Brian Jones and Peter Howick.
MEAT AND POULTRY TRACEABILITY IMPLEMENTATION GUIDE
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
B2C Extended Packaging Bar Code Standard
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
The Food and Drug Administration Amendments Act of 2007: Implications of the Drug Safety Provisions Carolyn D. Jones, J.D., MPh Director, Regulatory Policy.
SWIS Digital Inspections Project (SWIS DIP) Chris Allen, Information Management Branch California Integrated Waste Management Board November 5, 2008 The.
GS1 US INITIATIVES UPDATE MARCH 18, GS1 STANDARDS MAKES IT POSSIBLE 2 SAFETYSECURITY VISIBILITYEFFICIENCY COLLABORATION To apply standards to business.
Use of ISBT 128 in the Labeling of Cellular Therapy Products Pat Distler Technical Director, ICCBBA
Warranty Working Group Update. Warranty Working Group's Mission Review both new and existing technologies and business processes to develop a warranty.
LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP.
GDSN Mandatory Attributes -- Simplified Release date - 11 December 2008.
Apheresis Blood Components
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. REGULATORY INTELLIGENCE: INDUSTRY’S BEST PRACTICE OMICS 5 th International Pharmaceutical.
The Proposed Changes to NDC System Legacy NDC Numbers and Compliance December 11, 2006 Dr. Thomas F. Willer Director Global Regulatory Affairs.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
FDA Public Meeting on Electronic Records and Signatures June 11, 2004 Presentation of the Industry Coalition on 21CFR Part 11 Alan Goldhammer, PhD Chair.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
ISO Current status of development ​ ​ ISO development process ​1​1.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
1 Waste Discharge Authorization Application - British Columbia WG6 Application Process WG Document Review presented by Helga Harlander October x, 2008.
HIPAA Security Final Rule Overview
Update: AUL Guidance Revisions Summary of Comments June 23, 2011 Peggy Shaw Workgroup Chair.
EDQM anti-counterfeiting Traceability service for medicines.
GS1 DataMatrix Instructions
Use of Risk-based Approach for Regulating CMC Changes to Approved Applications FDA Public Meeting February 7, 2007.
When Supply Chain meets Care Delivery: Background on GS1 and HL7 Ulrike Kreysa Director Healthcare, GS1 Global Office.
Experience with NDC Numbers Manufacturer Packager/ Repackager Labeler/ Relabeler Distributor Private Label Distributors Trained by the FDA Participated.
Public Consultation Session: Consultation and Transparency Requirements for Offshore Petroleum Activities Francesca Astolfi A/g General Manager, Offshore.
1 Dublin 23/24 April CONCLUSIONS Regulatory Co-ordination Responses to Deliverables 3 and 4 due by 8 th May Papers redrafted to take comments into account.
GDSN Mandatory Attributes -- Simplified 3 December 2008.
Mark Cilia Director Inspectorate & Enforcement 7 th May, 2014 Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax:
1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.
Falsified Medicines and Drug Supply Chain Security Dr. Teri Stokes, Director GXP International, Concord, MA – USA www. GXPInternational.com
November 6, 2013 Purchasing Controls & Supplier Quality Best Practices Beyond Compliance for the Medical Device Industry AdvaMed 2013 Bernie Liebler Technology.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on the Somatic Cell.
Guidance Development Merton V. Smith, Ph.D., J.D. Director International Programs and Product Standards Center for Veterinary Medicine, FDA.
FDA 21 CFR Part 11 Compliance
GS1 DataMatrix Instructions
HIBC UDI IMPLEMENTATION FOR THE DENTAL INDUSTRY
Healthcare Product Supply Interoperability
MHRA GMP Inspection Deficiency Data Trend 2016
Assistant Deputy Under Secretary of Defense (Supply Chain Integration)
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
SPL Implementation Working Group Leyla Rahjou-Esfandiary October 2016
FDA GUI Summary of Contract Manufacturing Arrangement for Drugs: Quality Agreements November This summary was prepared by the Rx-360.
HL7 International January Working Group Meeting Health Care Device WG
Off-Highway Diagnostic Improvement Project
Mrs. Senick Perspectives in Art
Radiopharmaceutical Production
Presentation transcript:

1 Summary of FDA Guidance for Industry Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages Prepared by: Barbara W. Unger March 26, 2010 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks regulatory, legislative and policy developments relevant to pharmaceutical/medical device supply chain integrity. The summary is not intended to serve as comprehensive and formal interpretation or guidance (and should not replace your own review and analysis of any referenced source documents). If you have questions, please contact Maureen Hardwick, Rx-360 Secretariat, at or

2 Background 2007 FDAAA –Created Section 505D of FD&C Act –FDA must develop standards to secure supply chain –Includes standard numerical identifiers (SNI) Attached at point of manufacture or repackaging Package or pallet level Facilitates identification, authentication and tracking Draft Guidance published for comment in January, 2009 Final Guidance released March 26, 2010 –Addressed many industry concerns –Is not supported by national legislation or regulations –Intended to be the first of several guidances

SCOPE Identifies SNI at package level only “Package” is identified as smallest saleable unit Repackager is required to add unique SNI if changing “smallest saleable unit” from that of the manufacturer Guidance does not address –how to link multiple SNIs –Pallet or case level SNIs –Implementation or application issues for SNIs 3

Content of SNI for Drugs Should be NDC code + unique serial number –Referred to as sNDC Serial number, < 20 alpha numeric characters Some biologics do not have NDC –Alternatively they may utilize ISBT 128 NOT required to include batch number or expiry Location on package not specified –Must not obscure FDA required information –NDC and serial number locations not required to be contiguous –Scanning / viewing should not damage package integrity 4

Content of SNI for Drugs Flexible in terms of data carrier technology –2-dimensional bar code –RFID –Other? Should be BOTH human and machine readable Proposed SNI (sNDC) is compatible with GTIN international standard 5

6 For More Information Thank you